Message from the Managing Director’s Desk
As we continue to navigate the ever-changing clinical research industry, I am pleased to share some perspectives and developments within our company that will drive our future growth strategies.
We have made a paradigm shift in our operations in the US and Canada, with consolidation of Lambda Therapeutic Research’s Toronto, Canada clinic and bioanalytical laboratory into Novum operations. Canada’s state-of-the-art facility offers niche Pharmacokinetics (PK), Late Phase and Complex Bioanalytical services, which we feel would be a comprehensive value-add in your Drug development programs. By embracing the Novum brand, with its nearly fifty year history, as across our North American operations, we will deliver an enhanced, more seamless suite of services to our clients.
In the past year, we have maintained an impeccable regulatory track record, successfully clearing various international inspections across our global units. We have also further strengthened our global clinical trial management capabilities by strategically investing in scientific talent and expanding our global network of clinical sites. Our commitment to exceeding client expectations remains unwavering, and we continue to offer a comprehensive portfolio of early and late-phase services.
We are confident that our positive energy, unwavering integrity, and unwavering commitment will ensure we continue to meet and exceed client expectations, always.
Bindi Chudgar
Managing Director
Services
Turnkey Clinical Trial Management solution for YOUR drug development programs
Careers
Novum prides itself on its talented and dedicated team of employees. The Novum team is passionate about customer satisfaction, safety and study integrity. All Novum clinical staff members receive extensive training designed to continually hone and increase the skills of each employee.
Want to participate in a study?
Last year we paid over $6.6 million to participants of our research studies.